NO20023367D0 - Glyburide-preparat - Google Patents

Glyburide-preparat

Info

Publication number
NO20023367D0
NO20023367D0 NO20023367A NO20023367A NO20023367D0 NO 20023367 D0 NO20023367 D0 NO 20023367D0 NO 20023367 A NO20023367 A NO 20023367A NO 20023367 A NO20023367 A NO 20023367A NO 20023367 D0 NO20023367 D0 NO 20023367D0
Authority
NO
Norway
Prior art keywords
glyburide
preparation
glyburide preparation
Prior art date
Application number
NO20023367A
Other languages
English (en)
Other versions
NO20023367L (no
NO328152B1 (no
Inventor
Gillian Cave
Sarah J Nicholson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20023367D0 publication Critical patent/NO20023367D0/no
Publication of NO20023367L publication Critical patent/NO20023367L/no
Publication of NO328152B1 publication Critical patent/NO328152B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/59—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20023367A 2000-01-14 2002-07-12 Glyburid og glyburid-preparater samt anvendelse av disse for fremstilling av medikament for behandling av sykdom NO328152B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48370300A 2000-01-14 2000-01-14
PCT/US2001/000234 WO2001051463A1 (en) 2000-01-14 2001-01-04 Glyburide composition

Publications (3)

Publication Number Publication Date
NO20023367D0 true NO20023367D0 (no) 2002-07-12
NO20023367L NO20023367L (no) 2002-09-04
NO328152B1 NO328152B1 (no) 2009-12-21

Family

ID=23921174

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023367A NO328152B1 (no) 2000-01-14 2002-07-12 Glyburid og glyburid-preparater samt anvendelse av disse for fremstilling av medikament for behandling av sykdom

Country Status (37)

Country Link
US (2) US20010036479A1 (no)
EP (1) EP1250321B1 (no)
JP (1) JP4787446B2 (no)
KR (1) KR100739906B1 (no)
CN (1) CN1210258C (no)
AR (1) AR031547A1 (no)
AT (1) ATE330937T1 (no)
AU (1) AU771705B2 (no)
BG (1) BG65782B1 (no)
BR (1) BR0107564A (no)
CA (1) CA2397294C (no)
CY (1) CY1106328T1 (no)
CZ (1) CZ20022429A3 (no)
DE (1) DE60120916T2 (no)
DK (1) DK1250321T3 (no)
EE (1) EE05020B1 (no)
ES (1) ES2264967T3 (no)
GE (1) GEP20043299B (no)
HU (1) HU228825B1 (no)
IL (2) IL150383A0 (no)
LT (1) LT5024B (no)
LV (1) LV12914B (no)
MX (1) MXPA02006835A (no)
MY (1) MY128577A (no)
NO (1) NO328152B1 (no)
NZ (1) NZ519920A (no)
PT (1) PT1250321E (no)
RO (1) RO121381B1 (no)
RU (1) RU2244707C2 (no)
SK (1) SK286925B6 (no)
TN (1) TNSN01005A1 (no)
TR (1) TR200201798T2 (no)
TW (1) TWI287989B (no)
UA (1) UA73968C2 (no)
UY (1) UY26529A1 (no)
WO (1) WO2001051463A1 (no)
ZA (1) ZA200205528B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050271737A1 (en) * 2001-06-07 2005-12-08 Chinea Vanessa I Application of a bioactive agent to a substrate
US7767249B2 (en) * 2001-06-07 2010-08-03 Hewlett-Packard Development Company, L.P. Preparation of nanoparticles
CA2479748A1 (en) * 2002-03-21 2003-10-02 Guy Samburski Fine particle size pioglitazone
KR100897890B1 (ko) 2002-06-17 2009-05-18 인벤티아 헬스케어 피브이티. 엘티디. 티아졸리딘디온 및 바이구아나이드를 함유하는 다층 정제및 그의 제조 방법
EP1677792B1 (en) 2003-10-31 2015-11-18 Takeda Pharmaceutical Company Limited Solid preparation comprising pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester
CN100455279C (zh) * 2004-04-29 2009-01-28 美时化学制药股份有限公司 口服延迟释放锭剂组成物及其制法
JP2007534704A (ja) * 2004-04-29 2007-11-29 美時化学製薬股▲ふん▼有限公司 経口徐放性錠剤組成物およびその製造方法
CN100341495C (zh) * 2004-12-29 2007-10-10 三九医药股份有限公司 格列本脲固体分散体、口服组合物及其制备方法
WO2006109175A2 (en) * 2005-04-11 2006-10-19 Aurobindo Pharma Limited Solid dosage form of an antidiabetic drug
US8529537B2 (en) * 2005-08-05 2013-09-10 Kimberly-Clark Worldwide, Inc. Absorbent article with enclosures
JP5113752B2 (ja) 2005-08-22 2013-01-09 メリオール・ファーマスーティカルズ・ワン・インコーポレイテッド Ｌｙｎキナーゼの活性を調節し、関連する疾患を治療するための方法および製剤
CN101287467B (zh) * 2005-08-22 2011-01-19 梅里奥尔医药I公司 用于调节Lyn激酶活性和治疗相关病症的方法和制剂
JP2009537478A (ja) * 2006-05-13 2009-10-29 ノヴォ ノルディスク アクティーゼルスカブ レパグリニドとメトホルミンを含む錠剤配合物
WO2008026668A1 (fr) * 2006-08-31 2008-03-06 Daiichi Sankyo Company, Limited Composition médicale contenant un agent d'amélioration de la résistance à l'insuline
EP1967182A1 (en) * 2007-03-07 2008-09-10 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising a salt of rosigliatazone
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2010048287A2 (en) 2008-10-22 2010-04-29 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Radioprotective agents
EP2520298A1 (en) 2011-05-03 2012-11-07 Assistance Publique, Hopitaux De Paris Pharmaceutical composition comprising sulfonylureas (glibenclamide) or meglitinides for use for treating hyperglycaemia or for promoting growth of a premature infant
CN102743354A (zh) * 2012-07-31 2012-10-24 南京正科制药有限公司 瑞格列奈片及其制备方法
CN103142521B (zh) * 2013-03-21 2014-06-25 西南药业股份有限公司 格列本脲片及其制备方法
CN104127423A (zh) * 2014-07-30 2014-11-05 沈阳药科大学 格列喹酮衍生物及其制备方法和应用
CN104127424A (zh) * 2014-07-30 2014-11-05 沈阳药科大学 格列本脲衍生物及其制备方法和应用
MX2019012170A (es) 2017-04-10 2020-01-20 Melior Pharmaceuticals I Inc Tratamiento de adipocitos.
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法
WO2023012610A1 (en) * 2021-08-03 2023-02-09 Avaca Pharma Private Limited Formulations, compositions and methods for the treatment of stroke

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174901A (en) * 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
DE1185180B (de) 1963-10-19 1965-01-14 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
US3454635A (en) 1965-07-27 1969-07-08 Hoechst Ag Benzenesulfonyl-ureas and process for their manufacture
CA889876A (en) 1970-09-10 1972-01-04 Frank W. Horner Limited Purification of glyburide
US4060634A (en) * 1973-09-26 1977-11-29 Boehringer Mannheim G.M.B.H. Rapidly resorbable glibenclamide
DE2348334C2 (de) * 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
US4916163A (en) * 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
DE3833439A1 (de) 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
RU2026670C1 (ru) 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
US5258185A (en) 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
US5932245A (en) * 1991-12-05 1999-08-03 Alfatec Pharma Gmbh Gelatin or collagen hydrolysate containing drug formulation that provides for immediate release of nanoparticle drug compounds
DK36392D0 (da) * 1992-03-19 1992-03-19 Novo Nordisk As Anvendelse af kemisk forbindelse
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
US6153632A (en) * 1997-02-24 2000-11-28 Rieveley; Robert B. Method and composition for the treatment of diabetes
DE19721467A1 (de) * 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
KR20060105005A (ko) 1997-06-18 2006-10-09 스미스클라인비이참피이엘시이 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
GB9715306D0 (en) 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
PT996429E (pt) * 1997-10-27 2003-06-30 Merck Patent Gmbh Solucoes e dispersoes no estado solido de farmacosfracamente soluveis em agua
EP0974356B1 (en) 1998-07-15 2003-09-24 Merck Sante Tablets comprising a combination of metformin and glibenclamide
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents

Also Published As

Publication number Publication date
BG106870A (en) 2003-03-31
DE60120916T2 (de) 2007-02-15
NO20023367L (no) 2002-09-04
UY26529A1 (es) 2001-08-27
NO328152B1 (no) 2009-12-21
AU771705B2 (en) 2004-04-01
US6830760B2 (en) 2004-12-14
CA2397294C (en) 2011-03-22
LT2002085A (en) 2003-01-27
NZ519920A (en) 2004-06-25
AU2474001A (en) 2001-07-24
MXPA02006835A (es) 2003-01-28
ZA200205528B (en) 2003-10-10
BG65782B1 (bg) 2009-11-30
EE05020B1 (et) 2008-06-16
IL150383A0 (en) 2002-12-01
CY1106328T1 (el) 2011-10-12
AR031547A1 (es) 2003-09-24
BR0107564A (pt) 2002-10-01
CN1395560A (zh) 2003-02-05
EE200200393A (et) 2003-10-15
ES2264967T3 (es) 2007-02-01
DK1250321T3 (da) 2006-07-31
CN1210258C (zh) 2005-07-13
DE60120916D1 (de) 2006-08-03
RU2002121626A (ru) 2004-01-10
US20010036479A1 (en) 2001-11-01
ATE330937T1 (de) 2006-07-15
CA2397294A1 (en) 2001-07-19
TNSN01005A1 (en) 2005-11-10
UA73968C2 (en) 2005-10-17
US20030185880A1 (en) 2003-10-02
SK286925B6 (sk) 2009-07-06
RU2244707C2 (ru) 2005-01-20
HUP0203852A3 (en) 2005-05-30
EP1250321B1 (en) 2006-06-21
EP1250321A1 (en) 2002-10-23
JP4787446B2 (ja) 2011-10-05
LV12914B (en) 2003-01-20
KR20020073169A (ko) 2002-09-19
SK9832002A3 (en) 2003-07-01
PL356210A1 (en) 2004-06-14
KR100739906B1 (ko) 2007-07-16
LT5024B (lt) 2003-06-25
MY128577A (en) 2007-02-28
CZ20022429A3 (cs) 2003-06-18
HUP0203852A2 (hu) 2003-04-28
RO121381B1 (ro) 2007-04-30
WO2001051463A1 (en) 2001-07-19
JP2003519681A (ja) 2003-06-24
PT1250321E (pt) 2006-09-29
GEP20043299B (en) 2004-03-10
IL150383A (en) 2007-03-08
HU228825B1 (en) 2013-05-28
TR200201798T2 (tr) 2002-11-21
TWI287989B (en) 2007-10-11

Similar Documents

Publication Publication Date Title
NO20023367D0 (no) Glyburide-preparat
LU91910I2 (fr) Bocéprévir - Victrelis
DK1857105T3 (da) Kathartisk præparat
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
ATE312098T1 (de) Thiazinoxazolidinon
DE60133295D1 (de) Sulphoniumsalz-verbindung
DE60128599D1 (de) Arbeitsgerät
EE200200526A (et) Kapslid
DE50114386D1 (de) Ng
ATA2932001A (de) Schneefräse
DE60107598D1 (de) Smart-skin strukturen
EE200200150A (et) Preparaat
DE60143985D1 (de) Os
NO20024431D0 (no) Kapsler
ATE262530T1 (de) Indolochinazolinone
ATE298751T1 (de) 7-oxopyridoryrimidine
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de) Sulfonylguanidine
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
DE10052925B4 (de) Schaukelbett
ATE476423T1 (de) Benzoylpyridazine
ATE284887T1 (de) Thienopyrrolidinone
DE10054120B4 (de) Aufsparrendämmelement
ATA7092001A (de) Skibindungseinstellgerät

Legal Events

Date Code Title Description
MK1K Patent expired